ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,596,680 | $16,725,000 | 2.33% |
Artal Group S.A. | 150,000 | $698,000 | 0.01% |
Destination Wealth Management | 29,656 | $138,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $674,000 | 0.01% |
IHT Wealth Management, LLC | 563 | $2,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 695 | $3,000 | 0.00% |
NORTHERN TRUST CORP | 44,048 | $205,000 | 0.00% |
Vantage Investment Advisors, LLC | 25 | $0 | 0.00% |
UBS Group AG | 5,204 | $24,000 | 0.00% |
Legal & General Group Plc | 384 | $2,000 | 0.00% |